Kala Bio News Today

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) was up 0.1% during mid-day trading on Monday . The company traded as high as $7.10 and last traded at $6.97. Approximately 14,248 shares were traded during trading, a decline of 64% from the average daily volume of 39,852 shares. The stock had previously closed at $6.96. […]

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 4,539 shares of KALA BIO stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $6.73, for a total value of $30,547.47. Following the sale, the chief executive officer now directly owns 286,315 shares of […]

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 4,539 shares of KALA BIO stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $6.73, for a total value of $30,547.47. Following the completion of the sale, the chief executive officer now […]

Board of Trustees of The Leland Stanford Junior University raised its holdings in KALA BIO, Inc. (NASDAQ:KALA – Free Report) by 85.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,127 shares of the company’s stock after purchasing an additional 9,748 […]

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 100,000 shares, an increase of 48.4% from the September 15th total of 67,400 shares. Currently, 4.9% of the company’s stock are short sold. Based on an […]

KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totalling 9,200 shares, a drop of 87.8% from the August 15th total of 75,500 shares. Approximately 0.5% of the company’s shares are short sold. Based on an […]